Richiedi una copia del documento: RHAPSODY : Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis

Captcha code
Annulla